Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) announced that it plans to release its unaudited financial results for the quarter ended September 30, 2014, before the U.S. market opens on Tuesday, November 25, 2014. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) belongs to Technology sector. Its net profit margin is -12.20% and weekly performance is -5.44%. On last trading day company shares ended up $2.78. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) distance from 50-day simple moving average (SMA50) is -12.05%. Merck & Co. Inc. (NYSE:MRK) on Monday said long-awaited data from an 18,000-patient trial suggest the company will not have to write down the value of its blockbuster Zetia and Vytorin cholesterol drugs. Merck & Co. Inc. (NYSE:MRK) shares fell -0.89% in last trading session and ended the day at $58.81. MRK Gross Margin is 63.00% and its return on assets is 5.10%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is 3.87%. On Nov. 5, Civeo Corporation (NYSE:CVEO) reported net income for the quarter ended September 30, 2014 of $32.4 million, or $0.30 per diluted share. These results compare to net income of $39.6 million, or $0.37 per diluted share, for the third quarter of 2013. On 10 November, Civeo Corporation (NYSE:CVEO) shares fell -1.64% and was closed at $10.81. CVEO EPS growth in last 5 year was 0.00%. Civeo Corporation (NYSE:CVEO) year to date (YTD) performance is -52.34%. Vodafone Group Plc (ADR) (NASDAQ:VOD) reported a smaller decline in service revenue than analysts estimated, the latest wireless carrier to show signs of recovery in European markets. The shares jumped as much as 5.9 percent in London. Vodafone Group Plc (ADR) (NASDAQ:VOD) belongs to Technology sector. Its weekly performance is 0.06%. On last trading day company shares ended up $33.02. Vodafone Group Plc (ADR) (NASDAQ:VOD) distance from 50-day simple moving average (SMA50) is 1.33%.Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has named Senior Vice President Julie O'Neill to replace company co-founder Stephen Squinto when the executive vice president and chief global operations officer retires Jan. 1. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares advanced 1.03% in last trading session and ended the day at $195.80. ALXN Gross Margin is 91.50% and its return on assets is 13.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) quarterly performance is 21.90%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
